Chinese herbal formulas for treating hypertension in traditional Chinese medicine: Perspective of modern science

Hypertension Research

Volumn 36, Issue 7, 2013, Pages 570-579

  Xiong, Xingjiang ^a   Yang, Xiaochen ^a   Liu, Yongmei ^a   Zhang, Yun ^a   Wang, Pengqian ^b   Wang, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b Traditional Chinese Medicine Hospital of Mentougou District   (China)

Author keywords

Chinese herbal formulas; traditional Chinese medicine; treatment efficacy

Indexed keywords

ALDOSTERONE RECEPTOR ANTAGONIST; ALISKIREN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN ANTAGONIST; ANGIOTENSIN[1-7]; ANTIHYPERTENSIVE AGENT; BANXIA BAIZHU TIANMA DECOCTION; BERBERINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; CHYMASE INHIBITOR; DARUSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN RECEPTOR ANTAGONIST; HERBACEOUS AGENT; HUANGLIAN JIE DU TANG; ISOLIENSININE; ISORHYNCHOPHYLLINE; NIUHUANGJIANGYA DECOCTION; OMAPATRILAT; QINGXUANJIANGYA DECOCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITOR; RHYNCHOPHYLLINE; SAMPATRILAT; SITAXSENTAN; SONGLINGXUEMAIKANG CAPSULE; TEZOSENTAN; TIANMA GOUTENG YIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERTICIL;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHEMICAL COMPOSITION; CHINESE HERB; CHINESE MEDICINE; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; NONHUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SYMPATHETIC NERVE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

DRUGS, CHINESE HERBAL; ENDOTHELIAL CELLS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 84877957972     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.18     Document Type: Review

References (125)

1. Karen S, Simon S, Bernard JG. Hypertension: a global perspective. Circulation 2011; 123: 2892-2896.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252. (Pubitemid 37553153)
3. Furberg CD, Psaty BM, Pahor M, Alderman MH, Mulrow C. Clinical implications of recent findings from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) and other studies of hypertension. Ann Intern Med 2001; 135: 1074-1078. (Pubitemid 33151028)
4. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D. Impact of high normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
5. Yikona JI, Wallis EJ, Ramsay LE, Jackson PR. Coronary and cardiovascular risk estimation in uncomplicated mild hypertension: a comparison of risk assessment methods. J Hypertens 2002; 20: 2173-2182. (Pubitemid 35388235)
6. Giovanna L, Francesca V, Roberto P. RAAS inhibition and renal protection. Curr Pharm Des 2012; 18: 971-980.
7. Brown MJ. Aliskiren. Circulation 2008; 118: 773-784.
8. William BW, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W, Keefe DL. Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12, 000 patients with hypertension. J Clin Hypertens 2010; 12: 765-775.
9. Musini VM, Fortin PM, Bassett K, Wright JM. Blood pressure lowering efficacy of renin inhibitors for primary hypertension. Cochrane Database Syst Rev 2008; 4; doi:10.1002/14651858.CD007066.pub2.
10. Duprez DA, Munger MA, Botha J, Keefe DL, Charney AN. Aliskiren for geriatric lowering of systolic hypertension: a randomized controlled trial. J Hum Hypertens 2010; 24: 600-608.
11. Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52: 1749-1757.
12. Elisavet M, Matilda F, Moses SE, Dimitri PM, Evangelos NL. Aliskiren, a direct renin inhibitor, in clinical practice, a new approach in the treatment of hypertension. Curr Vasc Pharmacol 2010; 8: 344-362.
13. Xu H, Chen KJ. Integrative medicine: the experience from China. J Altern Complement Med 2008; 14: 3-7. (Pubitemid 351185427)
14. Xiong XJ, Chu FY, Li HX, He QY. Clinical application of the TCM classic formulae for treating chronic bronchitis. J Tradit Chin Med 2011; 31: 69-72.
15. Walker AF, Marakis G, Morris AP, Robinson PA. Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytother Res 2002; 16: 48-54. (Pubitemid 34116695)
16. Zhong GW, Chen MJ, Luo YH, Xiang LL, Xie QY, Li YH, Zhang C, Gao F. Effect of Chinese herbal medicine for calming gan and suppressing hyperactive yang on arterial elasticity function and circadian rhythm of blood pressure in patients with essential hypertension. Chin J Integr Med 2011; 17: 414-420.
17. Li H, Liu LT, Zhao WM, Liu JG, Yao MJ, Han YX, Shen YP, Liu XD, Liu L, Wang XM, Cai LL, Guan J. Effects of traditional and integrative regimens on quality of life and early renal impairment in elderly patients with isolated systolic hypertension. Chin J Integr Med 2010; 16: 216-221.
18. Macklin EA, Wayne PM, Kalish LA, Valaskatgis P, Thompsom J, Pian Smith MCM, Zhang Q, Stevens S, Goertz C, Prineas RJ, Buczynski B, Zusman RM. Stop hypertension with the acupuncture research program (SHARP): results of a randomized, controlled clinical trial. Hypertension 2006; 46: 838-845. (Pubitemid 44610995)
19. Li JJ, Lu ZL, Kou WR, Chen Z, Wu YF, Yu XH, Zhao YC and on behalf of the Chinese Coronary Secondary Prevention Study Group. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS). Clin Exp Hypertens 2010; 32: 491-498.
20. Stavro PM, Woo M, Heim TF, Leiter LA, Vuksan V. North American Ginseng exerts a neutral effect on blood pressure in individuals with hypertension. Hypertension 2005; 46: 406-411. (Pubitemid 41099177)
21. Li JJ, Lu ZL, Kou WR, Chen Z, Wu YF, Yu XH, Zhao YC and on behalf of the Chinese Coronary Secondary Prevention Study Group. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS). J Clin Pharmacol 2009; 49: 947-956.
22. Liu D, Lin H, Wang H, Zhou W, Chen G, Guo W, Ye J, Xu Z, Chen H, Chen XM, Lai Z, Xiang C. Influence of removing blood stasis and tonifying liver and kidney method on quality of life in patients with essential hypertension: randomized controlled observation. Chin J Clin Rehabil 2006; 10: 9-12.
23. Wang J, Xiong XJ. Control strategy on hypertension in Chinese medicine. Evid Based Complement Altern Med 2012 (doi:10.1155/2012/284847).
24. Wang H, Shang HC, Zhang JH, Chen J, Sun BZ, Shang DD, Xiang YZ, Cao HB, Ren M, Guo LP, Zhang BL. Niuhuang Jiangya preparation for treatment of essential hypertension: a systematic review. Liaoning Zhong Yi Za Zhi 2008; 35: 649-652.
25. Hu YX. Quantitative Analysis of Clinical Controlled Trials of Traditional Chinese Medicine and Systematic Evaluation of Randomized Controlled Trials Involving Traditional Chinese Medicine for Essential Hypertension. Guangzhou University of Chinese Medicine: Guangzhou, China, 2009.
26. Ren Y, Ou AH, Lin XZ, Lao YR. Meta-analysis of traditional Chinese medicine for essential hypertension. Shanxi Zhong Yi 2006; 27: 794-796.
27. Dong DX, Yao SL, Yu N, Yang B. Systematic review and meta-analysis of Tianma Gouteng Yin combined with enalapril for essential hypertension. Zhongguo Zhong Yi Ji Zheng 2011; 20: 762-764.
28. Zhang HW, Tong J, Zhou G, Jia H, Jiang JY. Tianma Gouteng Yin Formula for treating primary hypertension. Cochrane Database Syst Rev 2012, Art. No.: CD008166; doi:10.1002/14651858.CD008166.pub2, 2012.
29. Xu WJ, Li YL. Systematic review of clinical evidence about calm the liver and subdue yang therapy on the hypertension disease with syndrome of upper hyperactivity of liver yang. Zhonghua Zhong Yi Yao Za Zhi 2012; 27: 736-739.
30. Shi M, Zhang YH. Systematic review of replenishing kidney qi method for essential hypertension with kidney qi deficiency syndrome. Shandong Zhong Yi Za Zhi 2012; 31: 236-238.
31. Wang J, Xiong XJ. Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews. Evid Based Complement Altern Med 2012; 2012: Article ID 697237 (doi:10.1155/2012/697237).
32. Wang J, Yang XC, Feng B, Liu W, Li HX, Li XK, Qian WD, Chu FY, Xiong XJ. Is Yangxue Qingnao Granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension? Evid Based Complement Altern Med 2013; 2013: Article ID 540613 (http://dx.doi.org/10.1155/2013/540613).
33. Xiong XJ, Yang XC, Liu W, Feng B, Ma JZ, Du XL, Wang PQ, Chu FY, Li J, Wang J. Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Altern Med 2012; 2012: Article ID 271462 (doi:10.1155/2012/271462).
34. Wang J, Yao KW, Yang XC, Liu W, Feng B, Ma JZ, Du XL, Wang PQ, Xiong XJ. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid-Based Complement Altern Med 2012; 2012: Article ID 714805 (doi:10.1155/2012/714805).
35. Luiz AB, Cordovil I, Filho JB, Ferreira AS. Zangfu zheng (patterns) are associated with clinical manifestations of zang shang (target-organ damage) in arterial hypertension. Chin Med 2011; 6: 23.
36. Georg G, Colombet I, Durieux P, Ménard J, Meneton P. A comparative analysis of four clinical guidelines for hypertension management. J Hum Hypertens 2008; 22: 829-837.
37. Schillaci G, Sacchi N. Diurnal blood pressure variation and left ventricular mass. Am J Cardiol 1996; 77: 325. (Pubitemid 26059311)
38. Qian YS, Zhang WZ, Zhou HF, Wang GL. Relationship of blood pressure variability and TCM constitution classification in essential hypertension patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003; 23: 88-90.
39. Tao LL, Ma XC, Chen KJ. Clinical study on effect of Qing xuan tiao ya recipe in treating menopausal women with hypertension. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009; 29: 680-684.
40. Yu J, Xu FQ. Clinical observation on Qing xuan jiang ya decoction in treatment of essential hypertension with liver-kidney yin-deficiency and liver-yang hyperactivity syndrome. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2010; 8: 1-3.
41. Ji M. Evaluating the efficacy of the bezoar antihypertensive pill by ambulatory blood pressure monitoring. Zhong Cheng Yao 2009; 31: 11-13.
42. Zhao YF, Wu H, Zu HB. Antihypertensive effect of valsartan and levam lodipine besylate combinated with traditional Chinese medicine Song ling xue mai kang therapying patients after stroke evaluated by ambulatory blood pressure monitoring. Shi Yong Xin Nao Fei Xue Guan Bing Za Zhi 2011; 19: 575-577.
43. Fu L, Mao ZX, Wang J, Zheng TR, Wang SL. Effects of Song ling xue mai kang capsule on ambulatory blood pressure in treatment of essential hypertension: a single-blind randomized controlled trial. Zhong Xi Yi Jie He Xue Bao 2009; 7: 509-513.
44. Wang FQ. The effect of Song ling xue mai kang combined with amlodipine on reducing the blood pressure variability in patients with essential hypertension. Jilin Zhong Yi Yao 2011; 31: 149-150.
45. Lei ZY, Lin X. Analysis of Banxia baizhu tianma soup on blood pressure variability in menopausal patients with hypertension. Xian Dai Zhong Xi Yi Jie He Za Zhi 2009; 18: 449-450.
46. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31: 68-72. (Pubitemid 28124694)
47. Binggeli C, Corti R, Sudano I, Luscher TF, Noll G. Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension 2002; 39: 892-896. (Pubitemid 34437545)
48. Cai Y, Qi CL, Wu D, Gao L, Lv JH. The protecting effects of berberine on the hypertensive renal impairment in rats fed by enriched high fat-salt-fructose diet. Guangdong Yao Xue Yuan Xue Bao 2011; 27: 65-69.
49. Lu S, Zhang ZB, Gong SY, Su W, Zhu HJ. Effects of isoliensinine on left ventricular hypertrophy and its possible mechanism. Zhong hua Gao Xue Ya Za Zhi 2008; 16: 33-35.
50. Zhou JY, Mo ZX, Zhou SW. Effect of rhynchophy line on central neurotransmitter levels in amphetamine-induced conditioned place preference rat brain. Fitoterapia 2010; 5: 844-848.
51. Yu SY. The effect of Niuhuang jiang ya pills on blood pressure and sympathetic activity. Zhongguo Zhong Yao Za Zhi 2007; 32: 172-175.
52. Fischer JW, Stoll M, Hahnb AW, Ungera T. Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells. Cardiovasc Res 2001; 51: 784-791. (Pubitemid 32800720)
53. Lei Y, Lu QS, Ma XC, Chen KJ. Clinical study on effect of Qing xin capsule in treating patients with hypertension of mild or moderate degree. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005; 25: 114-118.
54. Gildea JJ, Wang X, Jose PA, Felder RA. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension 2008; 51: 360-366. (Pubitemid 351159951)
55. Chen Y, Huang YS. Effect of Xia xi oral liquid on blood pressure and the expression of myocardial angiotensin II type 1 receptor in spontaneously hypertensive rats. Zhongguo Lao Nian Xue Za Zhi 2007; 13: 1228-1230.
56. Yu SY. Effects on sympathetic nervous activity of Niuhuang jiang ya pellet on hypertension patients. China J China Mater Med 2004; 29 (Suppl): 116-120.
57. Yu SY, Yu ZA. The effects observation of Niuhuang jiang ya capsule in improving the sex-life quality for hypertension patients. China J China Mater Med 2004; 29 (Suppl): 114-116.
58. Jiang JY, Wang XZ, Luo SS, Wang X, Bian K, Yan Y. Effect of Banxia baizhu tianma decoction on the left ventricular hypertrophy of hypertrophied myocardium in spontaneously hypertensive rat. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 1061-1066.
59. Ye XY, Song H, Lu ZC. Effects of puerarin injection on the mRNA expression of AT1 and ACE2 in spontaneously hypertensive rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28: 824-827.
60. Bates DO. Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 2010; 87: 262-271.
61. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65: 550-563. (Pubitemid 40138976)
62. Herbert SP, Stainier DY. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol 2011; 12: 551-564.
63. Dimmeler S, Zeiher AM. Nitric oxide-an endothelial cell survival factor. Cell Death Differ 1999; 6: 964-968. (Pubitemid 29520797)
64. Abraham D, Dashwood M. Endothelin-role in vascular disease. Rheumatology (Oxford) 2008; 47: 23-24.
65. Zhang ZW, Yue GH, Luo Y. Effects of Huanglian jie du decoction on prothrombotic state in spontaneous hypertension rats. Zhongguo Shi Yan Fang Ji Xue Za Zhi 2011; 17: 105-108.
66. Liu JQ, Huang YS. Effect of Xia xi oral liquid on blood pressure, ET, NO and blood viscosity in spontaneously hypertensive rats. Zhongguo Lao Nian Xue Za Zhi 2009; 29: 1816-1817.
67. Chen ZQ, Hong L, Wang H, Yin QL, Lai HL, Lu LX. Effects of Tong xin luo capsule on platelet activating and inflammation factors as well as vascular endothelial function in patients with essential hypertension complicated with diabetes mellitus. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 376-379.
68. Yao L, Lv GY. Effect of Zhenge hypertension recipe on nitric oxide and endothelin in spontaneous hypertension rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 36-37.
69. Zhao YH, Xu YH, Guan Y, Xiang P. Effects of Yi nian jiang ya decoction containing serum on cytokines secretion of vascular endothelium of spontaneously hypertensive rats. Chin J Integr Med 2010; 16: 344-347.
70. Zhao YH, Liu YD, Guan Y, Liu NW. Effects of Yi nian jiang ya decoction on primary hypertension in early stage-a clinical observations on 40 patients. J Tradit Chin Med 2010; 30: 171-175.
71. Song CS, Li H, Wang L, Xu LR, Liu F, Luo ZG. Study on effect and mechanism of aged patients with simple systolic hypertension by Jiangya capsule. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 902-905.
72. Li H, Liu F, Cui L, Luo ZG, Liu FZ, Xu LR. Effect of Jiangya capsule on levels of serum nitric oxide synthase activity, malondialdehyde, plasma neuropeptide Y and homo-cysteine in patients with senile simple systolic hypertension. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003; 23: 898-901.
73. Jin L, Zhou WQ. Clinical study on Jiangya capsule in treating hypertension of aged patients with yin-deficiency and yang excess syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 832-834.
74. Jiang W, Zhang WG, Ma XS, Zhou SN. Clinical and experimental study on Jiang zhi tiao ya granule in treating essential hypertension and protecting function of vascular endothelium. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 18-20.
75. Cohuet G, Struijker BH. Mechanisms of target organ damage caused by hypertension: therapeutic potential. Pharmacol Ther 2006; 111: 81-98. (Pubitemid 43765539)
76. Tomiyama M, Horio T, Yoshii M, Takiuchi S, Kamide K, Nakamura S, Yoshihara F, Nakahama H, Inenaga K, Kawano Y. Masked hypertension and target organ damage in treated hypertensive patients. Am J Hypertens 2006; 19: 880-886. (Pubitemid 46106997)
77. Odama U, Bakris G. Target organ damage in hypertension. J Clin Hypertens (Greenwich) 2000; 2: 312-318.
78. Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R. Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 2006; 48: 397-403. (Pubitemid 44253732)
79. Zhang ZG, Wang C, Li L, Fan D, Fu FY, Wu LL. Effects of gadol and ganodcrma spores on the adiponcctin signal pathway in hypcrtrophic myocardium of spontaneous hypcrtcnsive rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009; 29: 233-237.
80. Wang S, Wang SR, Zhao YR, Dong AM. Study on effect of Jiang ya tong mai recipe on vascular activating substances in patients of hypertension with left ventricular hypertrophy. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 274-276.
81. Wang YH, Xiao WJ, Luo SQ, Wang C, Han JG, Shang T, Wang G. Effects of Jiang ya tong mai formula on blood pressure and left ventricular hypertrophy of spontaneous hypertensive rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 25: 369-371.
82. Xian SX, Hu SY, Liu XH, Zhao LC, Li NY. Study on effect of Tianma gouteng decoction in intervening myocardial collagen reconstruction in renovascular hypertensive rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2003; 23: 21-24.
83. Wang SJ, Chen Y, He DD, He LR, Yang YM, Chen JZ, Wang XX. Inhibition of vascular smooth muscle cell proliferation by serum from rats treated orally with Gastrodia and Uncaria decoction, a traditional Chinese formulation. J Ethnopharmacol 2007; 114: 458-462. (Pubitemid 350026229)
84. Ho SC, Ho YF, Lai TH, Liu TH, Su SY, Wu RY. Effect of Tianma Gouteng decoction with subtractive ingredients and its active constituents on memory acquisition. Am J Chin Med 2008; 36: 593-602.
85. Yao LM, Liu TW, Wu WF, Zhong GQ. Effects of astragalus injection in reversiong left ventricular hypertrophy induced by renal hypertension in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2009; 29: 918-921.
86. Zhou JZ, Lei H, Chen YZ, Li FQ. Effect of erigeron breviscapus injection on ventricular and vascular remodeling in spontaneous hypertension rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 122-125.
87. Wu DJ, Hong HS, Jiang Q. Effect of Shexiang baoxin pill in alleviating myocardial fibrosis in spontaneous hypertensive rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005; 25: 350-353.
88. Chen JY, Fan HL, Zhang SF. Effect of modified Zexie decoction on prevention of kidney injuries of rats with hypertension induced by high-salt diet. Zhong Yi Za Zhi 2012; 53: 234-237.
89. Huang L, Shi ZX, Zhang JL, Mao JS, Luo J. Experimental study on effect of Jiang ya mai jing liquid on spontaneous hypertension rats fed with high lipid diet. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 528-530.
90. Chu JF, Wu GW, Zheng GH, Zheng LP, Lin W, Huang MY, Huang YM, Lin RH, Yang ML, Zhou CE. Protective effect of Qing xuan jiang ya decoction on the kidney of spontaneous hypertension rats. Zhong Yi Za Zhi 2012; 53: 420-423.
91. Zhong GW, Li W, Chen MJ, Yi ZJ, Chen GL, Xiang LL. Effects on vascular remodeling and adiponectin expression in aorta in the spontaneously hypertensive rats by Chinese herb mixture method. Zhonghua Gao Xue Ya Za Zhi 2008; 16: 812-816.
92. Wang YX, Dang WY, Chen ZC, Wang SJ, He LR. Comparative study on effects of three therapeutic methods on vascular remodeling in spontaneous hypertension rats. Zhong Yi Za Zhi 2006; 47: 381-383.
93. Jing QW, Chen QL, Deng XG, Cong S, Wu ZZ. Effect of To n g m a i n i n g granule on blood pressure and vascular remodeling in spontaneous hypertensive rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002; 22: 34-35.
94. Zhao P, Chen J, Hong YD, Zeng YJ. Ultrasonographic study on effects of Wen dan xie zhuo method in improving vascular endothelial diastolic function and atherosclerosis in hypertension patients with turbid-phlegm syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007; 27: 21-24.
95. Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway. Curr Atheroscler Rep 2012; 14: 160-166.
96. Whaley CA, Sowers JR. Hypertension and insulin resistance. Hypertension 2009; 54: 462-464.
97. Cao L, Mao CP, Gu ZL. Effect of puerarin on glucose tolerance and the histomorphol-ogy in pancreatic tissue in insulin resistance rats. Zhongguo Xue Ye Liu Bian Xue Za Zhi 2008; 18: 47-49.
98. Zhu QL, He AX, Lv XR. Effects of puerarin on the scavenge of oxygen free radicals and the antagonism against oxidative injury. Jie Fang Jun Yao Xue Xue Bao 2008; 26: 2478-2480.
99. Wu QF, Wen MX, Lan DH. Effects of Banxia baizhu tianma decoction on salt sensitivity and blood lipid in hypertensive patients with abundant phlegm-dampness syndrome. Fujian Yi Yao Za Zhi 2007; 29: 146-148.
100. Wu QF, Wen MX, Lan DH. Effect of Banxia baizhu tianma decoction on insulin resistance and blood lipid in hypertensive patients with abundant phlegm-dampness syndrome. Fujian Zhong Yi Yao Xue Bao 2007; 17: 8-10.
101. Wang YS, Chen HG, Wu W. Clinical studies of Bu shen yi xin tablets on improving the insulin resistance in patients with essential hypertension. Xin Zhong Yi 2003; 35: 42-43.
102. Kwan CY, Achike F. Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: cardiovascular effects and mechanisms of action. Acta Pharmacol Sin 2002; 23: 1057-1068. (Pubitemid 35470328)
103. Lv GY, Chen SH, Lv HJ, Chen Y. Henostatic studies on anti-hypertensive effect of Xueling. Zhejiang Zhong Yi Xue Yuan Xue Bao 2003; 27: 47-49.
104. Weng JL. Song ling xue mai kang on hemorheology in patients with hypertension. Shi Yong Xin Nao Xue Guan Za Zhi 2006; 14: 885-886.
105. Ren JX, Lin CR, Wang M, Xu H, Liu JX. The effect and mechanism of Niuhuang jiang ya capsule on the function of platelets in rats. Zhongguo Shi Yan Fang Ji Xue Za Zhi 2007; 13: 34-36.
106. Liu JQ, Li HZ, Cui ZW, Huang SZ. Effect of Song ling xue mai kang on high-sensitivity C reactive protein and carotid artery atherosclerosis in hypertensive patients. Zhong Xi Yi Jie He Xin Nao Xue GuanBing Za Zhi 2011; 9: 266-267.
107. Kang YF, Zhang AM, Shu C. Effect of Niuhuang jiang ya pill on atherosclerosis. Jilin Zhong Yi Yao 2009; 29: 1044-1045.
108. Chen KJ. Clinical service of Chinese medicine. Chin J Integr Med 2008; 14: 163-164.
109. Chen KJ. Where are we going? Chin J Integr Med 2010; 16: 100-101.
110. Robinson N. Integrative medicine-traditional Chinese medicine, a model? Chin J Integr Med 2011; 17: 21-25.
111. Xiong XJ, Yang XC, Feng B, Liu W, Duan L, Gao A, Li HX, Ma JZ, Du XL, Li N, Wang PQ, Su KL, Chu FY, Zhang GH, Li XK, Wang J. Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Altern Med 2013; 2013: Article ID 982380 (http://dx.doi.org/10.1155/ 2013/982380).
112. Xu H, Chen KJ. Complementary and alternative medicine: is it possible to be mainstream? Chin J Integr Med 2012; 18: 403-404.
113. Xu H, Chen KJ. Making evidence-based decisions in the clinical pratice of integrative medicine. Chin J Integr Med 2010; 16: 483-485.
114. Liu MY, Chen KJ. Convergence: the tradition and the modern. Chin J Integr Med 2012; 18: 164-165.
115. Lee MS, Pittler MH, Taylor-Piliae RE, Ernst E. Tai chi for cardiovascular disease and its risk factors: a systematic review. J Hypertens 2007; 25: 1974-1975. (Pubitemid 47356640)
116. Lee MS, Choi TY, Shin BC, Kim JI, Nam SS. Cupping for hypertension: a systematic review. Clin Exp Hypertens 2010; 32: 423-425.
117. Lee MS, Lee MS, Choi ES, Chung HT. Effects of qigong on blood pressure, blood pressure determinants and ventilatory function in middle-aged patients with essential hypertension. Am J Chin Med 2003; 31: 489-497. (Pubitemid 41758835)
118. Lee MS, Lee EN, Kim JI, Ernst E. Tai chi for lowing resting blood pressure in the elderly: a systematic review. J Eval Clin Pract 2010; 16: 818-824.
119. Kim JI, Choi JY, Lee H, Lee MS, Ernst E. Moxibustion for hypertension: a systematic review. BMC Cardiovasc Disord 2010; 10: 33.
120. Lee MS, Lim HJ, Lee MS. Impact of qigong exercise on self-efficacy and other cognitive perceptual variables in patients with essential hypertension. J Altern Complement Med 2004; 10: 675-680. (Pubitemid 39167315)
121. Lee MS, Pittler M, Guo RL, Ernst E. Qigong for hypertension: a systematic review of randomized clinical trials. J Hypertens 2007; 25: 1525-1532. (Pubitemid 47056554)
122. Wang J, Wang PQ, Xiong XJ. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Intern Med 2012; doi:10.4172/2165-8048.1000113.
123. Wang J, Xiong XJ. Current situation and perspectives of clinical study in integrative medicine in China. Evid Based Complement Altern Med 2012; 2012: Article ID 268542 (doi:10.1155/2012/268542).
124. Xu H, Chen KJ. Integrating traditional medicine with biomedicine towards a patient-centered healthcare system. Chin J Integr Med 2011; 17: 83-84.
125. Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 2005; 26: 558-563.